Menu

Do Brighter Species’ Brains Emit Redder Light?

Photon emissions in the brain are red-shifted in more-intelligent species, though scientists dispute what that means.

Oct 1, 2016
Alison F. Takemura

EXCITED LIGHT: Neurons stimulated with the neurotransmitter glutamate produce biophotons, ultraweak pulses of light. PIXABAY, GDJ

EDITOR'S CHOICE IN NEUROSCIENCE

The paper
Z. Wang et al., “Human high intelligence is involved in spectral redshift of biophotonic activities in the brain,” PNAS, 113:8753–58, 2016.

Brain aglow
Neurons can emit ultraweak photons when stimulated by the abundant neurotransmitter glutamate, and experiments suggest that the emitted light can travel along rat nerve fibers. Yet most researchers don’t believe there’s enough evidence to say whether these so-called biophotons act as communication signals, according to Michal Cifra, who studies the phenomenon at the Institute of Photonics and Electronics in the Czech Academy of Sciences.

Catching some rays
To test for a biological role for biophotons, a team in China analyzed brain slices from six species of roughly increasing intelligence: bullfrog, chicken, mouse, pig, rhesus monkey, and human. The group
doused the tissues with the neurotransmitter glutamate and determined
the photon emissions’ wavelengths using a newly designed spectrometer.

Spectral shift
For the most part, the more intelligent the species, the longer the biophoton wavelength: from about 600 nm among bullfrogs to 700 nm among humans, on average. (Chickens’ biophotons had longer wavelengths than mice’s, suggesting to the authors that chickens are smarter.) Because red-shifted light has lower energy, this spectral slide could help species, if they do use light biologically, to expend less energy, says study coauthor Jiapei Dai of South-Central University for Nationalities in Wuhan. “It’s a correlation,” says Dai. “But maybe [it] gives an explanation for human high intelligence.”

Harsher light
Cifra and Vahid Salari, who studies biophotons at Isfahan University of Technology in Tehran, concur that the findings are novel. But the team’s conclusions overreach. Cifra doubts “whether this spectral shift is [really] caused by some evolutionary function, or [if] it is just a coincidental artifact of having tissues of differing molecular content.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.